Cited by 300Alzheimer's disease research and treatmentsAdvanced Proteomics Techniques and ApplicationsDementia and Cognitive Impairment Research

Biochemistry of Tau in Alzheimer’s disease and related neurological disorders

Sergeant, Nicolas, Bretteville, Alexis, Hamdane, Malika, Caillet-Boudin, Marie-Laure, Grognet, Pierre, Bombois, Stephanie, Blum, David, Delacourte, André +4 more·2008·Expert Review of Proteomics

Abstract

Microtubule-associated Tau proteins belong to a family of factors that polymerize tubulin dimers and stabilize microtubules. Tau is strongly expressed in neurons, localized in the axon and is essential for neuronal plasticity and network. From the very beginning of Tau discovery, proteomics methods have been essential to the knowledge of Tau biochemistry and biology. In this review, we have summarized the main contributions of several proteomic methods in the understanding of Tau, including expression, post-translational modifications and structure, in both physiological and pathophysiological aspects. Finally, recent advances in proteomics technology are essential to develop further therapeutic targets and early predictive and discriminative diagnostic assays for Alzheimer's disease and related disorders.

Integrity signals

Registry

Crossref · 10.1586/14789450.5.2.207

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The citation lists haven’t been fetched yet

References 161 · Cited by 300

Authors
Sergeant, N., Bretteville, A., Hamdane, M., Caillet-Boudin, M.-L., Grognet, P., Bombois, S., Blum, D., Delacourte, A., Pasquier, F., Vanmechelen, E., Schraen-Maschke, S., & Buée, L.
Affiliations
  • Inserm (FR)
  • Fujirebio (Belgium) (BE)
  • Université de Lille (FR)
Venue
Expert Review of Proteomics
Published
2008-04
Volume
5
Issue
2
Pages
207-224
ISSN
  • 1478-9450 (ISSN-L)
  • 1744-8387
OpenAlex
W2096278785
Cited by
300
References
161
Citations by year
2026: 9 · 2025: 10 · 2024: 16 · 2023: 8 · 2022: 22 · 2021: 21 · 2020: 25 · 2019: 20 · 2018: 16 · 2017: 17 · 2016: 14 · 2015: 18 · 2014: 26 · 2013: 16 · 2012: 23
FWCI
8.75
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Review of Proteomics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
tau protein, Alzheimer's disease, tauopathy, microtubule stabilization, microtubule assembly, post-translational modification, proteomics, therapeutic target, diagnostic biomarkers, neuroplasticity
MeSH terms
Alzheimer Disease, Humans, Nervous System Diseases, Protein Processing, Post-Translational, tau Proteins, Protein Isoforms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review